Brief: Nabriva Therapeutics Announces Date Of 1-For-25 Reverse Stock Split
15/09/2022 12:03
Sept 15 (Reuters) - Nabriva Therapeutics PLC NBRV.O :
* NABRIVA THERAPEUTICS ANNOUNCES DATE OF 1-FOR-25 REVERSE
STOCK
SPLIT
* NABRIVA THERAPEUTICS PLC - STOCK SPLIT WILL BE EFFECTIVE
FOR
TRADING PURPOSES ON NASDAQ AS OF COMMENCEMENT OF TRADING ON
SEPTEMBER 16, 2022
Source text for Eikon: ID:nGNXgm05
Further company coverage: NBRV.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Nabriva Therapeutics
See all newsBrief: Nabriva Therapeutics And Units Enter Asset Purchase Agreement With Sumitomo Pharma
Brief: Nabriva Therapeutics Says Received Delisting Determination Letter From Nasdaq
Brief: Nabriva Therapeutics Receives Notice Of Delisting Or Failure To Satisfy Continued Listing Rule From Nasdaq
Brief: Nabriva Therapeutics - On Jan 31, Co's Unit Entered Into Letter Agreement With 2 Units Of Merck & Co, About Distribution Agreement, Dated July 15, 2020
Brief: Nabriva Therapeutics Provides Corporate Update